Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Marshall Ethanolization, Pulmonary Vein Isolation and Line Completion for Ablation of Persistent Atrial Fibrillation

NCT04681872 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

NCT NCT04681872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04681872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Marshall Ethanolization, Pulmonary Vein Isolation and Line Completion for Ablation of Persistent Atrial Fibrillation
Lead sponsor
University Hospital, Bordeaux
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 20, 2021
Completion date
September 20, 2027
Enrollment
262 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation